ImmunoGen (IMGN)
(Real Time Quote from BATS)
$5.10 USD
+0.20 (4.08%)
Updated Jul 6, 2022 01:30 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
07/29/2022
Time: -- |
6/2022 | $-0.22 | 0.00% |
Earnings Summary
For their last quarter, ImmunoGen (IMGN) reported earnings of -$0.10 per share, beating the Zacks Consensus Estimate of $-0.21 per share. This reflects a positive earnings surprise of 52.38%. Look out for IMGN's next earnings release expected on July 29, 2022. For the next earning release, we expect the company to report earnings of -$0.22 per share, reflecting a year-over-year decrease of 46.67%.
Earnings History
Price & Consensus
Zacks News for IMGN
ImmunoGen (IMGN) Ovarian Cancer Drug BLA Gets Priority Review
IMGN: What are Zacks experts saying now?
Zacks Private Portfolio Services